Research Paper Volume 15, Issue 11 pp 5032—5051
CLDN5 identified as a biomarker for metastasis and immune infiltration in gastric cancer via pan-cancer analysis
Figure 2. The TCGA data were used to investigate correlations between CLDN5 expression and the major pathological stages including stage I, stage II, stage III, and stage IV. (A–E) Correlations between CLDN5 expression and the major pathological stages of BLCA BLCA, BRCA, COAD and ESCA. (F–J) Correlations between CLDN5 expression and the major pathological stages of HNSC, KICH, KIRP, LIHC, LUAD. (K–M) Correlations between CLDN5 expression and the major pathological stages of READ, THCA, and STAD. For log scale, Log2 (TPM+1) was used. * p < 0:05, ** p < 0:01, and *** p < 0:001.